MedTrace Logo

Investigating a Von Willebrand Factor (VWF) Functional Screening Assay for Assigning the Phenotypic Variants of Von Willebrand Disease (VWD)

NCT02466789 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 134

Last updated 2022-08-10

No results posted yet for this study

Summary

The purpose of this study is to improve the investigators ability to diagnose von Willebrand Disease (VWD), a common inherited bleeding disorder. This study will look at a new screening blood test used to determine if a person has VWD. This new screening blood test can determine a diagnosis more rapidly than current blood tests. Also this test could be available at local hospital labs rather than require samples to be sent to bigger more specialized labs.

Conditions

  • Von Willebrands Disease

Sponsors & Collaborators

  • Versiti

    collaborator OTHER

  • Jonathan Roberts

    lead OTHER

Principal Investigators

  • Jonathan Roberts, MD · Bleeding and Clotting Disorders Institute

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2021-12-31
Completion
2022-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02466789 on ClinicalTrials.gov